Dechra pleases with solid growth in revenues and dividend
Veterinary pharmaceuticals company Dechra Pharmaceuticals (DPH) reported full-year revenues up 6.8% to £515.1 million and underlying operating profits 0.7% ahead at £128.3 million. The dividend was increased by 8.5% to 34.39 pence...
07 September 2020